Metro Healthcare Berhad (KLSE:METRO)

Malaysia · Delayed Price · Currency is MYR

0.2300

+0.0200 (9.52%)

At close: Aug 11, 2026

12.20% (1Y)

Market Cap	225.15M +12.2%
Revenue (ttm)	50.52M +6.3%
Net Income	6.56M +111.6%
EPS	0.01 +120.2%
Shares Out	978.91M
PE Ratio	34.34
Forward PE	n/a
Dividend	0.01 (2.38%)
Ex-Dividend Date	Apr 6, 2026

Volume	1,610,200
Open	0.2100
Previous Close	0.2100
Day's Range	0.2100 - 0.2350
52-Week Range	0.2000 - 0.2450
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Metro Healthcare Berhad

Metro Healthcare Berhad, together with its subsidiaries, provides hospital and related services in Malaysia. It offers inpatient; outpatient; and ambulatory care, including in vitro fertilization (IVF), intrauterine insemination (IUI), blastocyst culture, surgical sperm retrieval, preimplantation genetic screening (PGT), and assisted hatching services. The company also provides fertility services, such as assisted reproductive technology and specialized fertility procedures; and obstetrics services that include pre-pregnancy screening and couns... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified

Founded 1989

Employees 204

Stock Exchange Bursa Malaysia

Ticker Symbol METRO

Full Company Profile

Financial Performance

In 2025, Metro Healthcare Berhad's revenue was 50.42 million, an increase of 3.63% compared to the previous year's 48.65 million. Earnings were 5.86 million, an increase of 28.56%.

Financial Statements